Barclays analyst Luke Sergott raised the firm’s price target on Illumina (ILMN) to $145 from $135 and keeps an Equal Weight rating on the shares. The firm says solid quarter-over-quarter NSX consumables growth shows continued demand for the 25B flowcell.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina price target raised to $145 from $130 at Canaccord
- Illumina Reports Q3 2024 Financial Results Amid Strategic Expansion
- Cathie Wood’s ARK Investment buys 153K shares of Illumina today
- Closing Bell Movers: Palantir jumps 13% after results
- ILMN Earnings: Illumina Stock Slips on Mixed Financial Results